T1	Value 0 18	Less than 18 years
T2	Person 22 25	age
R1	Has_value Arg1:T2 Arg2:T1	
T3	Condition 28 37	Pregnancy
T4	Drug 55 76	vitamin K antagonists
T5	Multiplier 40 47	Chronic
T6	Drug 80 106	direct thrombin inhibitors
T7	Drug 111 137	oral Xa-factor antagonists
*	OR T7 T6 T4
T8	Scope 55 137	vitamin K antagonists or direct thrombin inhibitors, or oral Xa-factor antagonists
R2	Has_multiplier Arg1:T8 Arg2:T5	
T9	Condition 140 156	Hypersensitivity
T10	Drug 160 172;194 199	antiplatelet drugs
T11	Drug 180 199	anticoagulant drugs
*	OR T11 T10
T12	Scope 160 199	antiplatelet and/or anticoagulant drugs
R3	Has_scope Arg1:T9 Arg2:T12	
T13	Condition 221 239	high bleeding risk
T14	Condition 209 217	bleeding
T15	Qualifier 202 208	Active
R4	Has_qualifier Arg1:T14 Arg2:T15	
T16	Condition 248 261	liver failure
T17	Qualifier 241 247	severe
R5	Has_qualifier Arg1:T16 Arg2:T17	
T18	Qualifier 263 269	active
T19	Condition 270 282	peptic ulcer
R6	Has_qualifier Arg1:T19 Arg2:T18	
T20	Measurement 284 304	creatinine clearance
T21	Value 305 316	< 30 mL/min
R7	Has_value Arg1:T20 Arg2:T21	
T22	Measurement 318 333	platelets count
T23	Value 334 347	< 100.000 mm3
R8	Has_value Arg1:T22 Arg2:T23	
*	OR T22 T20 T19 T16 T14 T13
T24	Qualifier 351 363	Uncontrolled
T25	Condition 364 385	systemic hypertension
R9	Has_qualifier Arg1:T25 Arg2:T24	
T26	Condition 388 405	Cardiogenic shock
T27	Procedure 417 453	myocardial revascularization surgery
T28	Temporal 408 416	Previous
R10	Has_temporal Arg1:T27 Arg2:T28	
T29	Device 463 479;497 502	internal mammary graft
T30	Device 483 502	radial artery graft
*	OR T29 T30
T31	Multiplier 459 462	= 1
T32	Scope 463 502	internal mammary or radial artery graft
R11	Has_multiplier Arg1:T32 Arg2:T31	
R12	Has_scope Arg1:T27 Arg2:T32	
T33	Qualifier 516 523	chronic
T34	Condition 524 551	peripheral arterial disease
T35	Procedure 578 595	femoral technique
T36	Negation 552 562	preventing
R13	Has_negation Arg1:T35 Arg2:T36	
R14	AND Arg1:T34 Arg2:T35	
R15	Has_qualifier Arg1:T34 Arg2:T33	
T37	Qualifier 598 604	Severe
T38	Temporal 605 616	concomitant
T39	Condition 617 624	disease
T40	Observation 630 645	life expectancy
T41	Value 646 661	below 12 months
R16	Has_value Arg1:T40 Arg2:T41	
R17	Has_temporal Arg1:T39 Arg2:T38	
R18	Has_qualifier Arg1:T39 Arg2:T37	
R19	Has_context Arg1:T39 Arg2:T40	
T42	Non-query-able 664 747	Participation in drug or devices investigative clinical trials in the last 30 days;
T43	Post-eligibility 749 893	Medical, geographic or social conditions impairing the participation in the study or inability to understand and sign the informed consent term.
